TherapeuticsMD Inc (TXMD)
1.88
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
TherapeuticsMD Price to Book Value: 0.7403 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.7403 |
| April 22, 2024 | 0.7403 |
| April 19, 2024 | 0.7324 |
| April 18, 2024 | 0.7442 |
| April 17, 2024 | 0.7442 |
| April 16, 2024 | 0.7482 |
| April 15, 2024 | 0.7679 |
| April 12, 2024 | 0.7836 |
| April 11, 2024 | 0.819 |
| April 10, 2024 | 0.8309 |
| April 09, 2024 | 0.8466 |
| April 08, 2024 | 0.8505 |
| April 05, 2024 | 0.8683 |
| April 04, 2024 | 0.882 |
| April 03, 2024 | 0.8761 |
| April 02, 2024 | 0.884 |
| April 01, 2024 | 0.9136 |
| March 28, 2024 | 0.9017 |
| March 27, 2024 | 0.886 |
| March 26, 2024 | 0.886 |
| March 25, 2024 | 0.9017 |
| March 22, 2024 | 0.9017 |
| March 21, 2024 | 0.9057 |
| March 20, 2024 | 0.9254 |
| March 19, 2024 | 0.9017 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.9057 |
| March 15, 2024 | 0.9451 |
| March 14, 2024 | 0.9293 |
| March 13, 2024 | 0.9372 |
| March 12, 2024 | 0.9391 |
| March 11, 2024 | 0.8781 |
| March 08, 2024 | 0.9175 |
| March 07, 2024 | 0.9017 |
| March 06, 2024 | 0.9647 |
| March 05, 2024 | 1.059 |
| March 04, 2024 | 1.038 |
| March 01, 2024 | 1.000 |
| February 29, 2024 | 0.9451 |
| February 28, 2024 | 0.9332 |
| February 27, 2024 | 0.9254 |
| February 26, 2024 | 0.9017 |
| February 23, 2024 | 0.886 |
| February 22, 2024 | 0.8899 |
| February 21, 2024 | 0.8899 |
| February 20, 2024 | 0.8939 |
| February 16, 2024 | 0.8899 |
| February 15, 2024 | 0.882 |
| February 14, 2024 | 0.9017 |
| February 13, 2024 | 0.882 |
| February 12, 2024 | 0.886 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7324
Minimum
Apr 19 2024
123.98
Maximum
Sep 25 2019
19.81
Average
1.340
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.651 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7236 |
| Theriva Biologics Inc | 0.1717 |
| Oragenics Inc | 3.100 |
Price to Book Value Related Metrics
| PS Ratio | 15.06 |
| Price | 1.88 |
| Earnings Yield | -52.66% |
| Market Cap | 21.68M |